Lexeo Therapeutics Inc (LXEO)

Operating Cash Flow Growth

35.35%

Quarterly · Period ending:

LXEO logo

LXEO Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported35.35%
LXEO Quarterly Cash from Operations YoY % (-21.72% → 35.35%)
High-resolution chart · PNG

LXEO operating cash flow growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc Operating Cash Flow Growth — Quarterly
Period endingOperating Cash Flow Growth
35.3503%
2.634%
29.1146%
-65.9384%
-35.0685%
-46.0685%
-102.6035%
-27.6507%
-52.7739%
19.0868%
15.9088%
-18.3222%
-19.3709%
-21.7241%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.